A current report in Lancet Resp. Med. includes the inaugural definition for the dysregulated immune responses in sepsis and a road map for studying and reclassifying the sepsis-related immune responses to enable drug discovery and targeted treatments. We highlight that many fundamental immunological concepts such as resistance, disease tolerance, resilience, resolution, and repair are not incorporated into the current sepsis immunobiology model.